E Fund Management Co., Ltd. Regenxbio Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$22.29 - $35.04 $20,328 - $31,956
-912 Reduced 10.17%
8,055 $213,000
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $107,702 - $195,032
5,566 Added 163.66%
8,967 $221,000
Q1 2021

May 12, 2021
BUY
$33.61 - $49.95 $114,307 - $169,879
3,401 New
3,401 $116,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
42.1M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $458M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email